Researchers identified a new receptor, neuropilin-1 (NRP1), which collaborates with a known receptor to regulate pain signaling from nerve growth factor. Unlike traditional signaling receptors, NRP1 acts as a co-receptor to enhance pain signals without directly transmitting them. The study showed how blocking NRP1 or disrupting its interaction with nerve growth factor could offer novel approaches to pain treatment.
